Last reviewed · How we verify
NCT06192901
Safety and Performance of Hydrophobic and Hydrophilic Intraocular Lenses After Bilateral Cataract Surgery
trial in Senile Cataract in 8 participants. Completed in 22 September 2023.
22 September 2023
Quick facts
| Lead sponsor | Carl Zeiss Meditec AG |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 8 |
| Start date | 18 September 2023 |
| Primary completion | 22 September 2023 |
| Estimated completion | 22 September 2023 |
| Sites | 1 location across El Salvador |
Conditions studied
- Senile Cataract — all drugs for Senile Cataract →
Sponsor
Carl Zeiss Meditec AG — full company profile →
Who can join
18 and older, any sex, with Senile Cataract. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Subjects who had a bilateral age-related cataract surgery with the IOLs AT ELANA 841P and AT LISA tri 839MP will be contacted and invited to attend a postoperative visit more than one year after the surgery
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06192901
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Carl Zeiss Meditec AG trials
Trials by the same sponsor.
- NCT07471295 — Toric Performance And Constant Evaluation · Phase 4 · not yet recruiting
- NCT07297719 — Evaluation of Glistening, Visual Outcomes and General Safety 24 Months Post-IOL Implantation · completed
- NCT06247683 — Study to Confirm Safety and Performance of a New Multifocal IOL · NA · completed
- NCT05646004 — 621 Real World Study · NA · unknown
- NCT05201027 — Study to Optimize the IOL Constant of a New Multifocal Intraocular Lens · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06192901 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Carl Zeiss Meditec AG
- Last refreshed: 5 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06192901.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing